Effects of hypoglycaemic agents on reducing surrogate metabolic parameters for the prevention of cardiovascular events and death in patients with type 2 diabetes: A systematic review and meta-analysis.
Alhassane DialloOrianne VillardMiguel Carlos-BolumbuPr Eric RenardFlorence GaltierPublished in: Diabetes, obesity & metabolism (2023)
In patients with type 2 diabetes, concomitant reductions in HbA1c and body weight might be more effective in preventing the risk of vascular events and mortality.